4-Amino-6-bromo-3,4-dihydro-2H-1-benzothiopyran hydrochloride, 97.0%, 100mg

(2E)-1-(3-bromophenyl)-3-(2,3-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(E)-ethyl 3-(2-chloro-4-(ethylamino)pyrimidin-5-yl)acrylate, 98%, 500mg

Syringe filters ROTILABO® Polytetrafluoroethylene (PTFE), 0,2 µm, 15 mm, Non-sterile, 100 Piece(s)

2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid, 98.0%, 500g

6-Chloromethyl-2-cyanopyridine, 95.0%, 10g

4-Nitrophenyl 2-bromoacetate, 98%, 5g

2,2,3,3,3-Pentafluoro-1-phenyl-1-pyridin-2-yl-propan-1-ol, 250mg

DL-2,3-Diaminopropionic acid monohydrochloride, 95.0%, 10g

[(2S)-2-METHYLOXETAN-2-YL]METHANOL, 95%, 100mg

7-Methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-9-(tetrahydro-2H-pyran-4-yl)-7H-purin-8(9H)-one, 98.0%, 10mg

2-Bromophenol>98.0%(GC)(T)100g

Decamethonium Bromide>98.0%(T)5g